Enavate Sciences Gp, LLC 13F holdings
Enavate Sciences Gp, LLC reported 7 positions with a total reported value of $345.4M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: SION SIONNA THERAPEUTICS INC (31.6%), ZBIO ZENAS BIOPHARMA INC (28.8%), IMNM IMMUNOME INC (22.2%), BBOT BRIDGEBIO ONCOLOGY THERAPEUT (5.8%), CMPX COMPASS THERAPEUTICS INC (4.9%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Enavate Sciences Gp, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
7 largest of 7 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| SION SIONNA THERAPEUTICS INC | 2,478,030 | $109.0M | 31.6% |
| ZBIO ZENAS BIOPHARMA INC | 3,919,159 | $99.5M | 28.8% |
| IMNM IMMUNOME INC | 3,613,799 | $76.6M | 22.2% |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 2,626,946 | $20.0M | 5.8% |
| CMPX COMPASS THERAPEUTICS INC | 7,788,150 | $17.1M | 4.9% |
| UPB UPSTREAM BIO INC | 2,459,703 | $17.0M | 4.9% |
| CAMP CAMP4 THERAPEUTICS CORP | 1,425,541 | $6.2M | 1.8% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| CAMP CAMP4 THERAPEUTICS CORP | 2,190,920 | 1,425,541 | -34.9% | $6.2M |
CIK 1953107 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
